China in talks with WHO over global use of Covid-19 vaccines

Published October 7, 2020
A worker performs a quality check in the packaging facility of Chinese vaccine maker Sinovac Biotech, developing an experimental coronavirus  vaccine, during a government-organised media tour in Beijing, China, September 24, 2020. — Reuters
A worker performs a quality check in the packaging facility of Chinese vaccine maker Sinovac Biotech, developing an experimental coronavirus vaccine, during a government-organised media tour in Beijing, China, September 24, 2020. — Reuters

SINGAPORE: China is in talks to have its locally-produced Covid-19 vaccines assessed by the World Health Organisation, as a step towards making them available for international use, a WHO official said on Tuesday.

Hundreds of thousands of essential workers and other groups considered at high risk in China have been given locally-developed vaccines even as clinical trials had not been fully completed, raising safety concerns among experts.

Socorro Escalate, WHO’s coordinator for essential medicines and health technologies in the Western Pacific region, told a news conference conducted online that China had held preliminary discussions with WHO to have its vaccines included in a list for emergency use.

The WHO’s emergency use listing procedure allows unlicensed vaccines and treatments to be assessed to expedite their availability in public health emergencies. This helps WHO member states and UN procurement agencies to determine the acceptability of the vaccines.

“Potentially through this emergency use listing the quality and safety of these vaccines and efficacy could be assessed... and then this could be made available for our licensees,” Escalante said.

China has at least four experimental vaccines in the final stage of clinical trials — two are developed by state-backed China National Biotec Group (CNBG), and the remaining two are from Sinovac Biotech and CanSino Biologics respectively. They are tested in such countries as Pakistan, Indonesia, Brazil, Russia and the United Arab Emirates.

Last month, the UAE authorised the emergency use of a CNBG vaccine, the first international emergency clearance for one of China’s vaccines, just six weeks after human trials began in the Gulf Arab state.

Published in Dawn, October 7th, 2020

Opinion

Editorial

1971 in retrospect
Updated 28 Nov, 2022

1971 in retrospect

The point of no return came when the military launched Operation Searchlight in March 1971.
Gender-based violence
28 Nov, 2022

Gender-based violence

IT is a war without boundaries and seemingly without end. A UN report on femicide released on Nov 25, the...
Battle against dacoits
28 Nov, 2022

Battle against dacoits

THE Punjab police is clearly fighting a formidable, and so far losing, battle against the criminal gangs based in ...
Policy rate hike
Updated 27 Nov, 2022

Policy rate hike

The decision to hike the policy rate by 100bps is a step in the right direction, even if intended to appease the IMF.
Vawda’s reprieve
27 Nov, 2022

Vawda’s reprieve

FAISAL Vawda should be relieved. After years of running from a reckoning for submitting a false declaration in his...
Gujarat’s ghosts
27 Nov, 2022

Gujarat’s ghosts

TWO decades have passed since the bloody Gujarat riots, one of the worst spasms of anti-Muslim violence witnessed in...